Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AZD9829 |
Trade Name | |
Synonyms | AZD 9829|AZD-9829 |
Drug Descriptions |
AZD9829 is an antibody-drug conjugate (ADC) comprising an IL3RA (CD123)-targeted antibody linked to the TOP1 inhibitor AZ14170132, which potentially induces DNA damage and apoptosis in IL3RA (CD123)-expressing cancer cells and inhibits tumor growth (Blood (2023) 142 (Supplement 1): 5957). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AZD9829 | AZD9829 | 0 | 1 |